The progesterone receptor Val660→Leu polymorphism and breast cancer risk

Breast Cancer Research

Volumn 6, Issue 6, 2004, Pages

  De Vivo, Immaculata ^a,b   Hankinson, Susan E ^a,b   Colditz, Graham A ^a,b   Hunter, David J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast cancer; Linkage disequilibrium; Polymorphism; Progesterone receptor

Indexed keywords

GUANINE; LEUCINE; PROGESTERONE RECEPTOR; THYMINE; VALINE;

ADULT; ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; EXON; FAMILY HISTORY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PROTEIN POLYMORPHISM; BLOOD; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUCINE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, PROGESTERONE; VALINE;

EID: 21644468552     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr928     Document Type: Article

References (20)

1. Colditz CA, Rosner B: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol. 2000, 152: 950-964. 10.1093/aje/152.10.950.
2. Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000, 92: 328-332. 10.1093/jnci/92.4.328.
3. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990, 9: 1603-1614.
4. Conneely OM, Maxwell BL, Toft DO, Schrader WT, O'Malley BW: The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun. 1987, 149: 493-501.
5. Conneely OM, Kettelberger DM, Tsai M-J, Schrader WT, O'Malley BW: The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J Biol Chem. 1989, 264: 14062-14064.
6. Wen DX, You-Feng X, Mais DE, Goldman ME, McDonnell DP: The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol. 1994, 14: 8356-8364.
7. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB: A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol. 1994, 8: 1347-1360. 10.1210/me.8.10.1347.
8. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP: The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol. 2000, 20: 3102-3115. 10.1128/MCB.20.9.3102-3115.2000.
9. Horwitz KB: The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer. Endocr Rev. 1992, 13: 146-163. 10.1210/er.13.2.146.
10. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB: Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem. 2002, 277: 5209-5218. 10.1074/jbc.M110090200.
11. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneely OM, O'Malley BW: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995, 9: 2266-2278.
12. Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW: Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999, 59: 4276-4284.
13. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM: Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci U S A. 2003, 100: 9744-9749. 10.1073/pnas.1732707100.
14. De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ: A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci U S A. 2002, 99: 12263-12268. 10.1073/pnas.192172299.
15. Manolitsas TP, Englefield P, Eccles DM, Campbell IG: No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Br J Cancer. 1997, 75: 1398-1399.
16. Lancaster JM, Berchuck A, Carney ME, Wiseman R, Taylor JA: Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer. 1998, 78: 277-
17. Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB: Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res. 2000, 60: 2348-2350.
18. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ: A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res. 2003, 63: 5236-5238.
19. Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G: The progesterone receptor exon 4 val660leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev. 2002, 11: 439-443.
20. Fabjani G, Tong D, Czerwenka K, Schuster E, Speiser P, Leodolter S, Zeillinger R: Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women. Breast Cancer Res Treat. 2002, 72: 131-137. 10.1023/A:1014813931765.